Overview

The Feasibility of Propofol TCI in Hemodialysis Patients Undergoing Arteriovenous Shunt Surgery

Status:
Completed
Trial end date:
2021-06-04
Target enrollment:
0
Participant gender:
All
Summary
Written informed consent must be obtained before any study specific procedures are undertaken. Informed consent will be obtained during pre-operative assessment.
Phase:
Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Treatments:
Propofol
Ropivacaine
Sevoflurane
Criteria
Inclusion Criteria:

- Uremic adult(over20-year-old)patients under going arteriovenous (AV) shunt surgery

Exclusion Criteria:

- one of below systemic diseases; chronic pulmonary, cardiac diseases(such as COPD,
asthma, acute myoischemia), hepatic co-mobility(such as liver cirrhosis), morbid
obesity, alcoholism, allergy to propofol and inhaled anesthetics, the women who are
pregnant or breastfeeding